The state of infection surveillance and control in Canadian acute care hospitals
The state of infection surveillance and control in Canadian acute care hospitals
复制标题
DOI：
10.1067/mic.2003.88
复制
发表时间：
2003-08-01
影响因子：
4.9
通讯作者：
Paton, S
中科院分区：
文献类型：
--
作者：
Zoutman, DE;Ford, BD;Paton, S
背景：医院感染和耐药病原体导致显著的发病率、死亡率和经济成本。感染监测和控制资源和活动在加拿大的急性护理hospitals没有被评估在20 years.Methods：在2000年，调查邮寄到感染控制计划在所有加拿大医院超过80急性护理病床。该调查是仿照美国医院感染控制有效性研究的仪器，增加了处理耐药病原体和计算机化的新项目。结果：238家医院中有172家（72.3%）做出了回应。在42.1%的医院中，每250张病床中不到1名感染控制从业人员。只有60%的感染控制项目有接受过感染控制培训的医生或博士专业人员提供服务。监测指数中位数为65.6/100，控制指数中位数为60.5/100。只有36.8%的hospital.Conclusions：在有效的感染控制计划的确定组成部分，手术部位感染率报告给个别外科医生。需要更多的资源投资，以达到推荐的标准，从而降低发病率，死亡率，并与医院感染和耐药病原体相关的费用。
Background: Nosocomial infections and antibiotic-resistant pathogens cause significant morbidity, mortality, and economic costs. The infection surveillance and control resources and activities in Canadian acute care hospitals had not been assessed in 20 years.Methods: In 2000, surveys were mailed to infection control programs in all Canadian hospitals with more than 80 acute care beds. The survey was modeled after the US Study on the Efficacy of Nosocomial Infection Control instrument, with new items dealing with resistant pathogens and computerization. Surveillance and control indices were calculated.Results: One hundred seventy-two of 238 (72.3%) hospitals responded. In 42.1% of hospitals, there was fewer than 1 infection control practitioner per 250 beds. Just 60% of infection control programs had physicians or doctoral professionals with infection control training who provided services. The median surveillance index was 65.6/100, and the median control index was 60.5/100. Surgical site infection rates were reported to individual surgeons in only 36.8% of hospitals.Conclusions: There were deficits in the identified components of effective infection control programs. Greater investment in resources is needed to meet recommended standards and thereby reduce morbidity, mortality, and expense associated with nosocomial infections and antibiotic-resistant pathogens.